<code id='B66E8F12A1'></code><style id='B66E8F12A1'></style>
    • <acronym id='B66E8F12A1'></acronym>
      <center id='B66E8F12A1'><center id='B66E8F12A1'><tfoot id='B66E8F12A1'></tfoot></center><abbr id='B66E8F12A1'><dir id='B66E8F12A1'><tfoot id='B66E8F12A1'></tfoot><noframes id='B66E8F12A1'>

    • <optgroup id='B66E8F12A1'><strike id='B66E8F12A1'><sup id='B66E8F12A1'></sup></strike><code id='B66E8F12A1'></code></optgroup>
        1. <b id='B66E8F12A1'><label id='B66E8F12A1'><select id='B66E8F12A1'><dt id='B66E8F12A1'><span id='B66E8F12A1'></span></dt></select></label></b><u id='B66E8F12A1'></u>
          <i id='B66E8F12A1'><strike id='B66E8F12A1'><tt id='B66E8F12A1'><pre id='B66E8F12A1'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:Wikipedia    Page View:74
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more
          Buoyed by wins on obesity, Novo Nordisk eyes heart disease
          Buoyed by wins on obesity, Novo Nordisk eyes heart disease

          AdobePHILADELPHIA—NovoNordisk,whichhasdominatedthediabetesandobesitymarketswithitsblockbusterdrugsOz

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Buoyed by wins on obesity, Novo Nordisk eyes heart disease

          AdobePHILADELPHIA—NovoNordisk,whichhasdominatedthediabetesandobesitymarketswithitsblockbusterdrugsOz